• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一份用于研究的人类心脏组织采集方案。

A Protocol for Collecting Human Cardiac Tissue for Research.

作者信息

Blair Cheavar A, Haynes Premi, Campbell Stuart G, Chung Charles, Mitov Mihail I, Dennis Donna, Bonnell Mark R, Hoopes Charles W, Guglin Maya, Campbell Kenneth S

机构信息

Department of Physiology, University of Kentucky, Lexington, KY.

Department of Pediatrics, Institute for Stem Cell & Regenerative Medicine, University of Washington, Seattle, WA.

出版信息

VAD J. 2016;2(1). doi: 10.13023/VAD.2016.12. Epub 2016 Jun 3.

DOI:10.13023/VAD.2016.12
PMID:28042604
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5199025/
Abstract

This manuscript describes a protocol at the University of Kentucky that allows a translational research team to collect human myocardium that can be used for biological research. We have gained a great deal of practical experience since we started this protocol in 2008, and we hope that other groups might be able to learn from our endeavors. To date, we have procured ~4000 samples from ~230 patients. The tissue that we collect comes from organ donors and from patients who are receiving a heart transplant or a ventricular assist device because they have heart failure. We begin our manuscript by describing the importance of human samples in cardiac research. Subsequently, we describe the process for obtaining consent from patients, the cost of running the protocol, and some of the issues and practical difficulties that we have encountered. We conclude with some suggestions for other researchers who may be considering starting a similar protocol.

摘要

本手稿描述了肯塔基大学的一项方案,该方案允许一个转化研究团队收集可用于生物学研究的人类心肌。自2008年启动该方案以来,我们已经获得了大量实践经验,并且希望其他团队能够从我们的努力中有所收获。迄今为止,我们已从约230名患者身上获取了约4000个样本。我们收集的组织来自器官捐献者以及因心力衰竭而接受心脏移植或心室辅助装置的患者。我们在稿件开头阐述了人类样本在心脏研究中的重要性。随后,我们描述了获取患者同意的过程、运行该方案的成本,以及我们遇到的一些问题和实际困难。最后,我们为其他可能考虑启动类似方案的研究人员提供了一些建议。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9b/5199025/e1a3f414f8e4/nihms-803778-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9b/5199025/94c49b2b3a85/nihms-803778-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9b/5199025/e1a3f414f8e4/nihms-803778-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9b/5199025/94c49b2b3a85/nihms-803778-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee9b/5199025/e1a3f414f8e4/nihms-803778-f0002.jpg

相似文献

1
A Protocol for Collecting Human Cardiac Tissue for Research.一份用于研究的人类心脏组织采集方案。
VAD J. 2016;2(1). doi: 10.13023/VAD.2016.12. Epub 2016 Jun 3.
2
Left Ventricular Assist Device Results: Single Center Experience.左心室辅助装置的结果:单中心经验。
Exp Clin Transplant. 2015 Nov;13 Suppl 3:149-52. doi: 10.6002/ect.tdtd2015.P80.
3
How does successful bridging with ventricular assist device affect cardiac transplantation outcome?使用心室辅助装置成功过渡对心脏移植结果有何影响?
Interact Cardiovasc Thorac Surg. 2011 Oct;13(4):405-9. doi: 10.1510/icvts.2011.273722. Epub 2011 Jul 25.
4
Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.诺瓦科尔心室辅助系统的临床经验。过渡到移植及向长期应用的转变。
J Thorac Cardiovasc Surg. 1991 Oct;102(4):578-86; discussion 586-7.
5
Institutional Cost Comparison Between Heart Transplants and Left Ventricular Assist Device Implantations.心脏移植与左心室辅助装置植入的机构成本比较。
Exp Clin Transplant. 2016 Dec;14(6):656-659. doi: 10.6002/ect.2015.0213. Epub 2016 Apr 7.
6
The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.桥接心脏移植的心室辅助装置支持对心脏移植后生存率的影响。
J Thorac Cardiovasc Surg. 2010 Jul;140(1):169-73. doi: 10.1016/j.jtcvs.2010.03.026. Epub 2010 May 7.
7
Impact of normalization strategy on cardiac expression of pro-inflammatory cytokines: evaluation of reference genes in different human myocardial regions after Left Ventricular Assist Device support.规范化策略对促炎细胞因子心脏表达的影响:左心室辅助装置支持后不同人心肌区域参考基因的评估。
Cytokine. 2013 Aug;63(2):113-22. doi: 10.1016/j.cyto.2013.04.021. Epub 2013 May 10.
8
Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.左心室辅助装置可降低心脏移植候选者的固定性肺动脉高压。
J Thorac Cardiovasc Surg. 2007 Mar;133(3):689-95. doi: 10.1016/j.jtcvs.2006.08.104.
9
Bowel obstruction due to retained intraperitoneal left ventricular assist device (LVAD) driveline.因腹腔内遗留左心室辅助装置(LVAD)驱动线导致的肠梗阻。
J Cardiothorac Surg. 2018 May 21;13(1):46. doi: 10.1186/s13019-018-0738-1.
10
Clinical outcomes after implantation of a centrifugal flow left ventricular assist device and concurrent cardiac valve procedures.植入离心流左心室辅助装置和同期心脏瓣膜手术的临床结果。
Circulation. 2014 Sep 9;130(11 Suppl 1):S3-11. doi: 10.1161/CIRCULATIONAHA.113.007911.

引用本文的文献

1
Stress relaxation rates of myocardium from failing and non-failing hearts.衰竭心脏和非衰竭心脏心肌的应力松弛率。
Biomech Model Mechanobiol. 2025 Feb;24(1):265-280. doi: 10.1007/s10237-024-01909-4. Epub 2024 Dec 31.
2
GelBox: open-source software to improve rigor and reproducibility when analyzing gels and immunoblots.GelBox:用于在分析凝胶和免疫印迹时提高严谨性和可重复性的开源软件。
Am J Physiol Heart Circ Physiol. 2024 Sep 1;327(3):H715-H721. doi: 10.1152/ajpheart.00144.2024. Epub 2024 Aug 2.
3
Microarray Analysis for Transcriptomic Profiling of Myocardium in Patients with Fatal Myocardial Infarction.

本文引用的文献

1
The process of installing REDCap, a web based database supporting biomedical research: the first year.安装REDCap(一个支持生物医学研究的基于网络的数据库)的过程:第一年
Appl Clin Inform. 2014 Nov 19;5(4):916-29. doi: 10.4338/ACI-2014-06-CR-0054. eCollection 2014.
2
Transmural heterogeneity of cellular level power output is reduced in human heart failure.在人类心力衰竭中,细胞水平功率输出的跨壁异质性降低。
J Mol Cell Cardiol. 2014 Jul;72:1-8. doi: 10.1016/j.yjmcc.2014.02.008. Epub 2014 Feb 20.
3
Epidemiology of heart failure.心力衰竭的流行病学。
用于致命性心肌梗死患者心肌转录组分析的微阵列分析
Biomedicines. 2023 Dec 13;11(12):3294. doi: 10.3390/biomedicines11123294.
4
Effect of the Novel Myotrope Danicamtiv on Cross-Bridge Behavior in Human Myocardium.新型肌肽 Danicamtiv 对人心肌肌球蛋白横桥行为的影响。
J Am Heart Assoc. 2023 Oct 17;12(20):e030682. doi: 10.1161/JAHA.123.030682. Epub 2023 Oct 7.
5
Detection of Parvovirus B19 genome in human heart tissue samples.检测人心脏组织样本中的细小病毒 B19 基因组。
BMC Res Notes. 2023 Sep 29;16(1):239. doi: 10.1186/s13104-023-06527-4.
6
Palmitoylation of the pore-forming subunit of Ca(v)1.2 controls channel voltage sensitivity and calcium transients in cardiac myocytes.钙通道 pore-forming 亚基棕榈酰化调控心肌细胞通道电压敏感性和钙离子瞬变。
Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2207887120. doi: 10.1073/pnas.2207887120. Epub 2023 Feb 6.
7
Sarcomere length affects Ca2+ sensitivity of contraction in ischemic but not non-ischemic myocardium.肌节长度影响缺血但不影响非缺血心肌收缩的钙离子敏感性。
J Gen Physiol. 2023 Mar 6;155(3). doi: 10.1085/jgp.202213200. Epub 2023 Jan 12.
8
Cardiac myosin motor deficits are associated with left ventricular dysfunction in human ischemic heart failure.心肌肌球蛋白马达功能障碍与人类缺血性心力衰竭的左心室功能障碍有关。
Am J Physiol Heart Circ Physiol. 2023 Feb 1;324(2):H198-H209. doi: 10.1152/ajpheart.00272.2022. Epub 2022 Dec 16.
9
Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies.心脏疾病中zDHHC5表达及其底物棕榈酰化的动态但不一致的改变。
Front Physiol. 2022 Oct 5;13:1023237. doi: 10.3389/fphys.2022.1023237. eCollection 2022.
10
Cardiac fibroblast sub-types reflect pathological cardiac remodeling .心脏成纤维细胞亚型反映病理性心脏重塑。
Matrix Biol Plus. 2022 Jun 6;15:100113. doi: 10.1016/j.mbplus.2022.100113. eCollection 2022 Aug.
Circ Res. 2013 Aug 30;113(6):646-59. doi: 10.1161/CIRCRESAHA.113.300268.
4
Altered ventricular torsion and transmural patterns of myocyte relaxation precede heart failure in aging F344 rats.衰老 F344 大鼠心力衰竭前,心室扭转和心肌细胞松弛的跨壁模式发生改变。
Am J Physiol Heart Circ Physiol. 2013 Sep 1;305(5):H676-86. doi: 10.1152/ajpheart.00797.2012. Epub 2013 Jun 21.
5
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会基金会/美国心脏协会实践指南工作组关于心力衰竭管理的指南:美国心脏病学会基金会/美国心脏协会报告
J Am Coll Cardiol. 2013 Oct 15;62(16):e147-239. doi: 10.1016/j.jacc.2013.05.019. Epub 2013 Jun 5.
6
Procurement of shared data instruments for Research Electronic Data Capture (REDCap).研究电子数据捕获(REDCap)共享数据工具的采购。
J Biomed Inform. 2013 Apr;46(2):259-65. doi: 10.1016/j.jbi.2012.10.006. Epub 2012 Nov 10.
7
A partnership approach for Electronic Data Capture in small-scale clinical trials.一种小规模临床试验中电子数据采集的合作方法。
J Biomed Inform. 2011 Dec;44 Suppl 1(Suppl 1):S103-S108. doi: 10.1016/j.jbi.2011.05.008. Epub 2011 May 30.
8
Epidemiology and risk profile of heart failure.心力衰竭的流行病学和风险特征。
Nat Rev Cardiol. 2011 Jan;8(1):30-41. doi: 10.1038/nrcardio.2010.165. Epub 2010 Nov 9.
9
Heart disease and stroke statistics--2010 update: a report from the American Heart Association.《2010年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2010 Feb 23;121(7):e46-e215. doi: 10.1161/CIRCULATIONAHA.109.192667. Epub 2009 Dec 17.
10
Large animal models of heart failure: a critical link in the translation of basic science to clinical practice.心力衰竭的大型动物模型:基础科学转化为临床实践的关键环节。
Circ Heart Fail. 2009 May;2(3):262-71. doi: 10.1161/CIRCHEARTFAILURE.108.814459.